In conclusion, the use of tPA as a biomarker holds promise as a valuable tool for identifying hemorrhagic strokes in case of stroke suspicion (including ischemic and mimics), both in pre‐hospital settings for patient triage and within hospital management. The gene discussed is PLAT; the disease is Stroke.